$VMNT
Vemanti Group, Inc.

2023 Q3 Form 10-Q Financial Statement

#000147793223006083 Filed on August 14, 2023

View on sec.gov

Income Statement

Concept 2023 Q3 2023 Q2 2022 Q2
Revenue $33.19K $41.90K $36.18K
YoY Change -5.43% 15.82% -3.99%
Cost Of Revenue $6.160K $5.361K $6.652K
YoY Change 17.8% -19.41% 31.75%
Gross Profit $27.03K $36.54K $29.53K
YoY Change -9.5% 23.75% -9.52%
Gross Profit Margin 81.44% 87.21% 81.61%
Selling, General & Admin $230.7K $363.0K $293.8K
YoY Change -3.84% 23.56% -37.7%
% of Gross Profit 853.25% 993.46% 995.02%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $8.040K $8.040K $190.00
YoY Change -2.31% 4131.58% -48.65%
% of Gross Profit 29.74% 22.0% 0.64%
Operating Expenses $238.7K $371.1K $293.8K
YoY Change -0.49% 26.29% -37.7%
Operating Profit -$211.7K -$334.5K -$264.3K
YoY Change 0.79% 26.58% -39.79%
Interest Expense -$7.080K -$5.020K $13.00
YoY Change -37363.16% -38715.38%
% of Operating Profit
Other Income/Expense, Net $0.00 $630.00 $186.00
YoY Change -100.0% 238.71% -89.37%
Pretax Income -$218.7K -$338.9K -$264.3K
YoY Change 0.72% 28.24% -40.41%
Income Tax $844.00 $0.00
% Of Pretax Income
Net Earnings -$219.6K -$338.9K -$264.3K
YoY Change 1.11% 28.24% -40.52%
Net Earnings / Revenue -661.57% -808.83% -730.48%
Basic Earnings Per Share $0.00 $0.00 $0.00
Diluted Earnings Per Share $0.00 $0.00 $0.00
COMMON SHARES
Basic Shares Outstanding 71.87M shares 71.17M shares 71.70M shares
Diluted Shares Outstanding 71.68M shares

Balance Sheet

Concept 2023 Q3 2023 Q2 2022 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $180.8K $230.9K $435.8K
YoY Change -43.23% -47.02% -5.08%
Cash & Equivalents $180.8K $230.9K $435.8K
Short-Term Investments $0.00
Other Short-Term Assets $0.00 $57.72K
YoY Change -100.0%
Inventory
Prepaid Expenses $0.00 $57.72K
Receivables $18.77K $16.18K $7.606K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $199.6K $304.8K $443.4K
YoY Change -64.69% -31.27% -9.18%
LONG-TERM ASSETS
Property, Plant & Equipment $261.00
YoY Change -73.95%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $0.00
YoY Change -100.0%
Total Long-Term Assets $281.4K $289.4K $321.8K
YoY Change -10.28% -10.07% 8.2%
TOTAL ASSETS
Total Short-Term Assets $199.6K $304.8K $443.4K
Total Long-Term Assets $281.4K $289.4K $321.8K
Total Assets $480.9K $594.2K $765.3K
YoY Change -45.28% -22.35% -2.6%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $16.50K $13.05K $20.23K
YoY Change 83.91% -35.47% 98.95%
Accrued Expenses $109.4K $90.09K $342.8K
YoY Change -75.26% -73.72% 119.24%
Deferred Revenue
YoY Change
Short-Term Debt $280.0K $276.9K $125.0K
YoY Change 124.0% 121.48%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $414.3K $384.4K $488.1K
YoY Change -28.12% -21.24% 193.05%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $414.3K $384.4K $488.1K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $414.3K $384.4K $488.1K
YoY Change -28.12% -21.24% 193.05%
SHAREHOLDERS EQUITY
Retained Earnings -$5.236M -$5.016M -$3.845M
YoY Change 28.9% 30.47% 76.91%
Common Stock $7.187K $7.172K $7.170K
YoY Change 3.9% 0.03% 2.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $66.64K $209.8K $277.2K
YoY Change
Total Liabilities & Shareholders Equity $480.9K $594.2K $765.3K
YoY Change -45.28% -22.35% -2.6%

Cashflow Statement

Concept 2023 Q3 2023 Q2 2022 Q2
OPERATING ACTIVITIES
Net Income -$219.6K -$338.9K -$264.3K
YoY Change 1.11% 28.24% -40.52%
Depreciation, Depletion And Amortization $8.040K $8.040K $190.00
YoY Change -2.31% 4131.58% -48.65%
Cash From Operating Activities -$50.08K -$217.3K -$104.8K
YoY Change -57.33% 107.33% -46.65%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities $5.890K
YoY Change
Cash From Investing Activities $5.890K
YoY Change -158.9%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 250.0K 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -50.08K -217.3K -104.8K
Cash From Investing Activities 5.890K
Cash From Financing Activities 0.000 250.0K 0.000
Net Change In Cash -50.08K 32.66K -98.94K
YoY Change -57.33% -133.01% -147.45%
FREE CASH FLOW
Cash From Operating Activities -$50.08K -$217.3K -$104.8K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2022Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
191470 usd
CY2023Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
5214906 usd
CY2022Q4 us-gaap Preferred Stock Value
PreferredStockValue
4000 usd
CY2022Q2 us-gaap Cost Of Revenue
CostOfRevenue
6652 usd
us-gaap Cost Of Revenue
CostOfRevenue
10892 usd
CY2023Q2 us-gaap Gross Profit
GrossProfit
36543 usd
us-gaap Net Income Loss
NetIncomeLoss
-693996 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001605057
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2022Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
40000000 shares
CY2022Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
40000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
40000000 shares
CY2022Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2022Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
71715503 shares
CY2022Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
70351709 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2023-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-56266
dei Entity Registrant Name
EntityRegistrantName
VEMANTI GROUP, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
46-5317552
dei Entity Address Address Line1
EntityAddressAddressLine1
7545 Irvine Center Dr.
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address Address Line2
EntityAddressAddressLine2
Ste 200
dei Entity Address City Or Town
EntityAddressCityOrTown
Irvine
dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
92618
dei City Area Code
CityAreaCode
949
dei Local Phone Number
LocalPhoneNumber
559-7200
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
dei Entity Ex Transition Period
EntityExTransitionPeriod
false
dei Entity Shell Company
EntityShellCompany
false
CY2023Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
71865503 shares
CY2023Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
230893 usd
CY2022Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
257512 usd
CY2023Q2 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
16181 usd
CY2022Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
889 usd
CY2023Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
57719 usd
CY2022Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
242307 usd
CY2023Q2 us-gaap Assets Current
AssetsCurrent
304793 usd
CY2022Q4 us-gaap Assets Current
AssetsCurrent
500708 usd
CY2023Q2 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
289391 usd
CY2022Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
305469 usd
CY2023Q2 us-gaap Assets Noncurrent
AssetsNoncurrent
289391 usd
CY2022Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
305469 usd
CY2023Q2 us-gaap Assets
Assets
594184 usd
CY2022Q4 us-gaap Assets
Assets
806177 usd
CY2023Q2 us-gaap Accounts Payable Current
AccountsPayableCurrent
13054 usd
CY2022Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6262 usd
CY2023Q2 us-gaap Interest Payable Current
InterestPayableCurrent
4418 usd
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
1250 usd
CY2023Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
90087 usd
CY2023Q2 us-gaap Notes Payable
NotesPayable
151851 usd
CY2022Q4 us-gaap Notes Payable
NotesPayable
0 usd
CY2023Q2 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
125000 usd
CY2022Q4 us-gaap Due To Officers Or Stockholders Current
DueToOfficersOrStockholdersCurrent
125000 usd
CY2022Q4 us-gaap Liabilities Current
LiabilitiesCurrent
323982 usd
CY2023Q2 us-gaap Liabilities
Liabilities
384410 usd
CY2022Q4 us-gaap Liabilities
Liabilities
323982 usd
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
40000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71715503 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70351709 shares
CY2022Q4 us-gaap Common Stock Value
CommonStockValue
7035 usd
CY2023Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-5016304 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
209774 usd
CY2023Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
594184 usd
CY2023Q2 us-gaap Revenues
Revenues
41904 usd
CY2022Q2 us-gaap Revenues
Revenues
36181 usd
us-gaap Revenues
Revenues
72226 usd
us-gaap Revenues
Revenues
73781 usd
CY2023Q2 us-gaap Cost Of Revenue
CostOfRevenue
5361 usd
us-gaap Cost Of Revenue
CostOfRevenue
12173 usd
CY2022Q2 us-gaap Gross Profit
GrossProfit
29529 usd
us-gaap Gross Profit
GrossProfit
61334 usd
us-gaap Gross Profit
GrossProfit
61608 usd
CY2023Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
363044 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
293824 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
735339 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
622774 usd
CY2023Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
8039 usd
CY2022Q2 us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
16078 usd
us-gaap Adjustment For Amortization
AdjustmentForAmortization
0 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
371083 usd
CY2022Q2 us-gaap Operating Expenses
OperatingExpenses
293824 usd
us-gaap Operating Expenses
OperatingExpenses
751417 usd
us-gaap Operating Expenses
OperatingExpenses
622774 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-334540 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-264295 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-690083 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-561166 usd
CY2023Q2 us-gaap Other Income
OtherIncome
627 usd
CY2022Q2 us-gaap Other Income
OtherIncome
234 usd
us-gaap Other Income
OtherIncome
1105 usd
us-gaap Other Income
OtherIncome
670 usd
CY2023Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
5018 usd
CY2022Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
13 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
5018 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
13 usd
CY2022Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
0 usd
CY2022Q2 us-gaap Gain Loss On Disposition Of Other Financial Assets
GainLossOnDispositionOfOtherFinancialAssets
-221 usd
us-gaap Gain Loss On Disposition Of Other Financial Assets
GainLossOnDispositionOfOtherFinancialAssets
0 usd
us-gaap Gain Loss On Disposition Of Other Financial Assets
GainLossOnDispositionOfOtherFinancialAssets
-221 usd
CY2023Q2 us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-4391 usd
CY2023Q2 us-gaap Gain Loss On Disposition Of Other Financial Assets
GainLossOnDispositionOfOtherFinancialAssets
0 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-3913 usd
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
436 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-338931 usd
CY2022Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-264295 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-693996 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-560730 usd
CY2023Q2 us-gaap Provision For Other Losses
ProvisionForOtherLosses
0 usd
CY2022Q2 us-gaap Provision For Other Losses
ProvisionForOtherLosses
0 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
0 usd
us-gaap Provision For Other Losses
ProvisionForOtherLosses
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-338931 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
-264295 usd
us-gaap Net Income Loss
NetIncomeLoss
-693996 usd
us-gaap Net Income Loss
NetIncomeLoss
-560730 usd
CY2023Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
CY2022Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.00
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.01
CY2023Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
CY2022Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.00
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.01
CY2023Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
71360723 shares
CY2022Q2 us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
71683540 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
70911564 shares
us-gaap Weighted Average Number Of Shares Issued Basic
WeightedAverageNumberOfSharesIssuedBasic
71319834 shares
CY2023Q2 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
71360723 shares
CY2022Q2 us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
71683540 shares
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
70911564 shares
us-gaap Pro Forma Weighted Average Shares Outstanding Diluted
ProFormaWeightedAverageSharesOutstandingDiluted
71319834 shares
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
482195 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
100000 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
321575 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
209774 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
71843 usd
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
337500 usd
us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
428580 usd
us-gaap Net Income Loss
NetIncomeLoss
-560730 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
277193 usd
us-gaap Net Income Loss
NetIncomeLoss
-693996 usd
us-gaap Net Income Loss
NetIncomeLoss
-560730 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
0 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
371 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
0 usd
us-gaap Gains Losses On Sales Of Assets
GainsLossesOnSalesOfAssets
221 usd
vmnt Amortization Expense
AmortizationExpense
16078 usd
vmnt Amortization Expense
AmortizationExpense
0 usd
us-gaap Share Based Compensation
ShareBasedCompensation
220192 usd
us-gaap Share Based Compensation
ShareBasedCompensation
344119 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
1851 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
0 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-15292 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-3191 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
184588 usd
us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
0 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
6792 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
15727 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
3168 usd
us-gaap Increase Decrease In Accrued Taxes Payable
IncreaseDecreaseInAccruedTaxesPayable
0 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-276619 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-203483 usd
us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
0 usd
us-gaap Proceeds From Sale Of Foreclosed Assets
ProceedsFromSaleOfForeclosedAssets
5886 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
0 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
5886 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
150000 usd
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
100000 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
337500 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
250000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
337500 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-26619 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
139903 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
257512 usd
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
295937 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
230893 usd
CY2022Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
435840 usd
us-gaap Interest Paid
InterestPaid
0 usd
us-gaap Interest Paid
InterestPaid
13 usd
vmnt Exchange Of Due From Fvndit For Intangible Assets
ExchangeOfDueFromFvnditForIntangibleAssets
0 usd
vmnt Exchange Of Due From Fvndit For Intangible Assets
ExchangeOfDueFromFvnditForIntangibleAssets
25142 usd
vmnt Exchange Of Intangible Assets For Assets
ExchangeOfIntangibleAssetsForAssets
0 usd
vmnt Exchange Of Intangible Assets For Assets
ExchangeOfIntangibleAssetsForAssets
321547 usd
us-gaap Finite Lived Intangible Assets Purchase Accounting Adjustments
FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments
0 usd
us-gaap Finite Lived Intangible Assets Purchase Accounting Adjustments
FiniteLivedIntangibleAssetsPurchaseAccountingAdjustments
296405 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
101383 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
234516 usd
us-gaap Reclassifications
Reclassifications
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Certain amounts reported in the prior year condensed consolidated financial statements have been reclassified to conform to the current year’s presentation.</p>
us-gaap Use Of Estimates
UseOfEstimates
<p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions. These estimates and assumptions affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting periods. Significant estimates made by management include, among others, allowances for doubtful accounts, valuation allowance for deferred income taxes and recoverability of intangible assets. Actual results could differ from those estimates. It is possible that accounting estimates and assumptions may be material to the Company due to the levels of subjectivity and judgment involved.</p>
vmnt Stock Issued During Period Value For Cash
StockIssuedDuringPeriodValueForCash
321575 usd
vmnt Time Based Restricted Stock Units And Restricted Stock Awards Vesting Period
TimeBasedRestrictedStockUnitsAndRestrictedStockAwardsVestingPeriod
vest over 3 to 4 years
vmnt Customer Concentration
CustomerConcentration
0.50 pure
CY2023Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000 shares
CY2023Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
40000000 shares
CY2023Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
500000000 shares
CY2023Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2023Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
71715503 shares
CY2022Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
70351709 shares
vmnt Stock Issued During Period Shares For Cash
StockIssuedDuringPeriodSharesForCash
895000 shares
CY2023Q2 us-gaap Restricted Investments At Fair Value
RestrictedInvestmentsAtFairValue
320763 usd
CY2022Q2 us-gaap Accounts Receivable Net
AccountsReceivableNet
25000 usd
CY2023Q2 us-gaap Investments
Investments
0 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
305469 usd
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
0 usd
vmnt Proprietary Informations
ProprietaryInformations
0 usd
CY2022 vmnt Proprietary Informations
ProprietaryInformations
321547 usd
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
16078 usd
CY2022 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
16078 usd
CY2023Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
289391 usd
CY2022Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
305469 usd
vmnt Finite Lived Intangible Assets Useful Life
FiniteLivedIntangibleAssetsUsefulLife
P10Y

Files In Submission

Name View Source Status
vmnt-20230630_lab.xml Edgar Link unprocessable
vmnt-20230630_cal.xml Edgar Link unprocessable
0001477932-23-006083-index-headers.html Edgar Link pending
0001477932-23-006083-index.html Edgar Link pending
0001477932-23-006083.txt Edgar Link pending
0001477932-23-006083-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vmnt-20230630.xsd Edgar Link pending
vmnt_10q.htm Edgar Link pending
vmnt_ex311.htm Edgar Link pending
vmnt_ex312.htm Edgar Link pending
vmnt_ex321.htm Edgar Link pending
vmnt_ex322.htm Edgar Link pending
vmnt-20230630_def.xml Edgar Link unprocessable
vmnt-20230630_pre.xml Edgar Link unprocessable
vmnt_10q_htm.xml Edgar Link completed